Incentives + Reminders for Depression
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, you must not have been treated with antidepressants in the past 90 days to participate.
What data supports the effectiveness of the treatment Personalized Daily Text Messages with Financial Incentives for depression?
Research shows that financial incentives can improve engagement in digital mental health interventions, which are effective in reducing symptoms of depression and anxiety. However, a study found no difference in engagement or mental health outcomes when financial incentives were added to a digital mental health app, suggesting that while incentives may help engagement, they might not enhance treatment outcomes.12345
How does the treatment of personalized daily text messages with or without financial incentives for depression differ from other treatments?
This treatment is unique because it uses personalized daily text messages to support individuals with depression, with the option of adding financial incentives to increase engagement. Unlike traditional therapies, this approach leverages digital communication and behavioral economics principles to encourage positive behavior changes and maintain social connections, which are risk factors for depression.12367
What is the purpose of this trial?
The goal of this randomized controlled trial study is to compare different adherence support strategies for primary care patients with depression who have been newly prescribed antidepressant medications. We will examine whether personalized daily text messages with and without financial incentives improves anti-depressant adherence and depression symptoms as compared to treatment as usual (no messages or incentives for taking medications).We will measure adherence with a wireless pill bottle and by assessment of electronic health prescription records. Participants in the study will be asked to complete assessments of depression symptoms via telephone at 6 and 12 weeks.
Eligibility Criteria
This trial is for adults aged 21-64 with a clinical diagnosis of major depressive disorder, who score at least 10 on the PHQ-9, have been prescribed antidepressants by their primary care doctor, are interested in medication adherence, own a cell phone and can use an electronic pill bottle. They must be Penn Medicine primary care outpatients.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive personalized daily text reminders with or without financial incentives to improve antidepressant adherence
Follow-up
Participants are monitored for antidepressant adherence and depression symptoms after treatment
Treatment Details
Interventions
- Personalized Daily Text Messages with Financial Incentives
- Personalized Daily Text Messages without Financial Incentives
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor